NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review

A Smolinska, L Blanchet, LMC Buydens… - Analytica chimica …, 2012 - Elsevier
Metabolomics is the discipline where endogenous and exogenous metabolites are
assessed, identified and quantified in different biological samples. Metabolites are crucial …

Chemometrics in metabolomics—a review in human disease diagnosis

R Madsen, T Lundstedt, J Trygg - Analytica chimica acta, 2010 - Elsevier
Metabolomics is a post genomic research field concerned with developing methods for
analysis of low molecular weight compounds in biological systems, such as cells, organs or …

The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes

MC Thomas, J Moran, C Forsblom, V Harjutsalo… - Diabetes …, 2011 - Am Diabetes Assoc
OBJECTIVE Many guidelines recommend reduced consumption of salt in patients with type
1 diabetes, but it is unclear whether dietary sodium intake is associated with mortality and …

Type 1 diabetes, metabolic syndrome and cardiovascular risk

JJ Chillarón, JAF Le-Roux, D Benaiges, J Pedro-Botet - Metabolism, 2014 - Elsevier
Patients with type 1 diabetes mellitus (T1DM) traditionally had a low body mass index and
microangiopathic complications were common, while macroangiopathy and the metabolic …

Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study

J Osipova, DC Fischer, S Dangwal… - The Journal of …, 2014 - academic.oup.com
Context: Circulating microRNAs (miRNAs/miRs) are used as novel biomarkers for diseases.
miR-21, miR-126, and miR-210 are known to be deregulated in vivo or in vitro under …

[HTML][HTML] Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)

FM Van der Kloet, FWA Tempels, N Ismail… - Metabolomics, 2012 - Springer
Diabetic kidney disease (DKD) is a devastating complication that affects an estimated third
of patients with type 1 diabetes mellitus (DM). There is no cure once the disease is …

Metabolomics in diabetic complications

LA Filla, JL Edwards - Molecular BioSystems, 2016 - pubs.rsc.org
With a global prevalence of 9%, diabetes is the direct cause of millions of deaths each year
and is quickly becoming a health crisis. Major long-term complications of diabetes arise from …

[HTML][HTML] Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes

D Pongrac Barlovic, V Harjutsalo, N Sandholm… - Diabetologia, 2020 - Springer
Aims/hypothesis Lipid abnormalities are associated with diabetic kidney disease and CHD,
although their exact role has not yet been fully explained. Sphingomyelin, the predominant …

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria

C Forsblom, V Harjutsalo, LM Thorn… - Journal of the …, 2011 - journals.lww.com
Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes.
The competing risks of death and ESRD may confound the estimates of risk for each …

Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: an inflammatory story

LM Hinder, BJ Murdock, M Park, DE Bender… - Experimental …, 2018 - Elsevier
Diabetic peripheral neuropathy is the most common complication of diabetes and a source
of considerable morbidity. Numerous molecular pathways are linked to neuropathic …